Patents Assigned to Natsu Maruyama
  • Patent number: 6020325
    Abstract: A method for inhibiting replication of HIV, which comprises subjecting HIV-infected cells to a composition (a) comprising as a primary component a polysaccharide derived from a hot aqueous solvent extract of tubercle bacillus.
    Type: Grant
    Filed: March 9, 1999
    Date of Patent: February 1, 2000
    Assignees: Zeria Pharmaceutical Co., Ltd., Natsu Maruyama
    Inventors: Fujio Suzuki, Hidetaka Sasaki, Makiko Kobayashi
  • Patent number: 6015796
    Abstract: The present invention relates to a method for treating AIDS, which comprises administering to an HIV-infected patient (a) a composition containing as the primary component a polysaccharide derived from a hot water extract of human-type tubercle bacillus and (b) a nucleoside-type anti-HIV agent. Due to the incorporation of composition (a), the present invention enhances the therapeutic effect of nucleoside-type anti-HIV agents on AIDS.
    Type: Grant
    Filed: March 11, 1998
    Date of Patent: January 18, 2000
    Assignees: Zeria Pharmaceutical Co., Ltd., Natsu Maruyama
    Inventors: Fujio Suzuki, Hidetaka Sasaki, Makiko Kobayashi